新着情報

Date: Sep 25-26, 2013
Venue: SunTec Singapore

http://www.techventure.com.sg/

http://imsaj.com/news/

Min-Liang Tan is the Chief Gamer and CEO of the Razer Group, the world’s leading brand in gaming hardware, where he plays an instrumental role in shaping Razer’s success in its current years of unprecedented growth both within the company and the gaming industry. As one of the co-founders of the company, he has built the company from inception to a multi-million dollar global organization.
Born in Singapore, he is now based in California where he oversees the company’s global operations spanning offices in the USA, Germany, Singapore, China, Korea and Taiwan.

We welcome you to join us this August, when Min-Liang Tan talks about “Life is Just a Game”.

Details of the event are as follows:
A unique feature of U@live is that not only will it be viewed by a live audience, it will be streamed live through a dedicated website (www.nus.edu.sg/ualive). The event will also incorporate a new interactive application that allows users to post questions and vote for their favourite questions in real time. The event will consist of a 10-minute talk by the speaker followed by a 20-minute interview conducted by Mr Viswa Sadasivan and a 30-minute Q&A session open to the live and online audience.

Date: 28th August 2013 (Wednesday)
Time: 7:30 pm – 8:30 pm (Registration at 6:45pm, Seated at 7:15pm, Cocktail reception after event)
Location: Auditorium (2nd Storey), Shaw Foundation Alumni House, 11 Kent Ridge Drive, Singapore 119244

We sincerely hope that you will be able to join us for this event. Please click here to register.

We look forward to seeing you there!

Healthcare & Lifestyle Programme Office MEDTECH CONVENTION 2013

26-27 Aug 2013 @ Matrix, Biopolis

Full program

http://123.136.65.78/Events/Event_2013Aug_ASTAR_MedTech_Convention2013.htm

Inaugural A*STAR MedTech Convention 2013 sets scene for future growth of MedTech industry in Singapore

1. The inaugural two-day A*STAR MedTech Convention 2013 organised by A*STAR brings together clinicians, scientists, business figures and global Key Opinion Leaders to share and exchange the latest in MedTech R&D and business developments. The event incorporates the Singapore-Stanford Biodesign (SSB) Thought Leaders Series as well as an exhibition to showcase MedTech projects and capabilities by A*STAR and its partners.

2. Over two days (26 – 27 August 2013), participants will hear from industry leaders in the MedTech sector, including Dr. Bijan Dorri, Chief Technology Officer for Healthcare Systems, GE Healthcare and Dr. Frederic H. Moll, Chairman and CEO of Auris Surgical Robotics and Founder of Intuitive Surgical. There will also be plenary sessions for participants to interact and discuss about nascent topics such as Asian trends in MedTech, clinical trends and challenges, product development and commercialisation.

3. More than 500 participants have signed up for the A*STAR MedTech Convention – this response exceeds the initial target by 20%. In addition to industry partners as well as clinicians and scientists from the R&D community, international experts from the US, Japan and South Korea will also be attending. The overwhelming response, both locally and internationally, reflects an urgent need for a platform like the A*STAR MedTech Convention 2013.

4. “We are encouraged that the MedTech Convention has been over-subscribed and I believe this shows the rising importance of medical technology to our economy. This platform fills a need to showcase Singapore’s unique value proposition for local and international businesses to turn any innovative medical idea seamlessly into commercially viable solutions,” said Associate Professor Tan Sze Wee, Deputy Executive Director of A*STAR Biomedical Research Council.

5. MedTech was identified as a strategic area since it could leverage on Singapore’s strengths in engineering, manufacturing and biomedical sciences. Over the past decade, MedTech output in Singapore has tripled, reaching US$3.43bil in 2012. Additionally, MedTech is the source of 9,000 jobs in Singapore.

6. “I am pleased that we have generated significant buzz in the MedTech sector in just four years since A*STAR initiated the MedTech programme in 2009. Through the collaboration with Stanford in the Singapore-Stanford Biodesign Program, we are nurturing the next generation of medical device innovators; through the collaboration with the community of clinicians in Boston (CIMIT), we are putting in place a process to better develop and testbed solutions in our own hospitals and polyclinics; and through the Biomedical Engineering Program, we have brought together a community of 1,200 clinicians, allied health practitioners, engineers and scientists to interact with each other on a regular basis and funded a portfolio of MedTech projects that will be of relevance to the clinical community. These initiatives have catalysed the growth of private sector activities and public-private partnerships on the sector leading to a richer and more robust MedTech ecosystem,” said Mr. Lim Chuan Poh, Chairman of A*STAR.

7. For more information on the programme and speakers at the MedTech Convention, please see Annex A. Highlights of projects that will be exhibited at the MedTech Convention can be found in Annex B.

About the Agency for Science, Technology and Research (A*STAR)

The Agency for Science, Technology and Research (A*STAR) is the lead agency for fostering world-class scientific research and talent for a vibrant knowledge-based and innovation-driven Singapore. A*STAR oversees 14 biomedical sciences and physical sciences and engineering research institutes, and six consortia & centres, located in Biopolis and Fusionopolis as well as their immediate vicinity.

A*STAR supports Singapore's key economic clusters by providing intellectual, human and industrial capital to its partners in industry. It also supports extramural research in the universities, and with other local and international partners.

For more information about A*STAR, please visit www.a-star.edu.sg

About the Healthcare and Lifestyle (H&L) Programme Office

The Healthcare & Lifestyle (H&L) Programme Office is set up as a strategic initiative for cross-disciplinary research across the Science and Engineering Research Council (SERC) and the Biomedical Research Council (BMRC). It oversees cluster and industry development of the Medical Technology (MedTech), Food Science & Nutrition and Personal Care clusters within A*STAR as well as throughout Singapore.

For more information, visit www.a-star.edu.sg/healthcareandlifestyle/

The 15th Asian Chemical Congress (15 ACC)
Date : Aug 19-23, 2013
Venue : Resorts World™ Sentosa

Speaker: Product Manager Robert Tapella (Pacific Biosciences)
Title: Applications of PacBio SMRT Sequencing in Genomics and Epigenetics Research

Venue: Amphitheatre, Level 2, Duke-NUS Grad Med Sch, 8 College Road, S169857
(Opposite Singapore General Hospital, Block 6/7)
Date/Time: Thursday, 15th August 2013, 10:30 AM – 11:30 AM

Abstract:
DNA sequencing technology has advanced rapidly in the past decade. However, there are significant limitations to massively parallel sequencing approaches, particularly related to short read lengths of tens or hundreds of bases per read, and with an inability to read through low complexity areas of the genome.

PacBio SMRT Sequencing is a new technology with read lengths of thousands of bases per read. Recent publications suggest that this method is able to close and finish high-accuracy bacterial genomes with automated software rather than requiring additional manual efforts. The read length is also beneficial to analysis of targeted genomic areas that are difficult or impossible to sequence using any other commercially available technology. Additionally, one may use SMRT Sequencing to study a variety of chemical modifications to DNA that can affect biochemical processes such as gene expression, replication and DNA repair.

This presentation will cover PacBio's SMRT Sequencing approach, which is a single-molecule analysis technology that can supplement or replace Sanger and massively parallel short-read sequencing approaches by addressing their limitations. Topics include:
- How the sequence of single molecules may be read
- The high read length and accuracy of single molecule sequencing
- Application of the features of SMRT Sequencing to genome assembly and targeted sequencing experiments
- Direct detection of chemically modified DNA bases and methylomes

About the Speaker:
Robert Tapella - Product Manager at Pacific Biosciences
Rob has over ten years of experience working in the biotechnology cluster of Silicon Valley. His experience spans genomics software to consumables and instrumentation at companies such as Applied Biosystems and Illumina. As product manager at Pacific Biosciences, Rob is managing development of the PacBio RS II System as well as analysis software for bacterial methylation and other base modification research.

Rob is a graduate of Cornell University, and did his Masters degree at Keck Graduate Institute, a multidisciplinary graduate school for the bioscience industry. The program combines business with study in biology, drug development, medical devices and diagnostics, intellectual property issues, regulatory affairs, and bioethics.

We have a new working paper titled “The EU And ASEAN – In Search Of A New Regional Paradigm?” by Dr Yeo Lay Hwee, Director, EU Centre in Singapore.

The Association of Southeast Asian Nations (ASEAN) has been seen as a relatively successful regional organisation in the developing world and has often been compared to the European Union (EU), the most successful model of regional integration thus far. As ASEAN approaches the 2015 deadline for the ASEAN Community project while Europe grapples with the aftermath of the Eurocrisis, it is worth considering the journey these two organisations have taken so far and ponder the road ahead.

This Working Paper seeks to provide a comparative overview of regionalism in the EU and ASEAN, incorporates analysis of external forces and internal dynamics shaping the respective regional processes, sketches the global trends that could impact regional developments in Europe and Asia and examines whether both organisations would need a new approach or paradigm to maintain their relevance in this 21st century world.

Another activity – EURAXESS Science Slam ASEAN 2013 invites all young researchers of any nationality and from any academic discipline, residing in ASEAN, to submit a 3-minute video (in English) to showcase their projects. The deadline for submission is Sunday, 18th August 2013.

If you have an idea that you’re passionate about and would like to present to the world, please don’t miss this opportunity to participate in this year’s EURAXESS Science Slam. Come out on top and the prize will be a free trip to Brussels to participate in the EURAXESS Voice of the Researchers Conference in November 2013!

The EURAXESS Science Slam ASEAN 2013 is organised by the EURAXESS Link ASEAN and supported by the European Commission. EURAXESS Link is an information and networking tool that aims to provide researchers with an important resource for European research, to maintain the link of Europe with European and non-European researchers, scientists and scholars in ASEAN and to stimulate scientific cooperation between Europe and ASEAN. This year’s EURAXESS Science Slam is an inaugural event that aims to raise the awareness of research and scientific cooperation between Europe and ASEAN.

We encourage all researchers to participate. All you have to do is to make that video and post your video online at the EURAXESS Facebook page, Linkedin or send the link to your video to asean@euraxess.net. A jury will then select 5 finalists to compete in the finals to be held at the Paulaner Brauhaus at Millenia Walk, Singapore in front of a live audience on 25 September.

More details on the Science Slam can be found on the slam trailer and at the Science Slam website ; For more details on EURAXESS Links ASEAN, please go to http://ec.europa.eu/euraxess/index.cfm/links/eurRes/asean/ .

Yours Sincerely
European Union Centre in Singapore
11 Slim Barracks Rise, #06-01 Executive Centre,
NTU@one-north campus, Singapore 138664
Tel: +65 6513 2003
www.eucentre.sg

アドレス：Helios, #10-12, 11 Biopolis Way, Singapore 138667

http://mnhexperience.com/

Date: July 22-23, 2013
Venue: Level 5 Seminar room, T-lab building, National University of Singapore

http://academic-medicine.org/announcement/opening-academia

Officially opened on 20 July 2013 by His Excellency President Tony Tan, the 13-storey purpose-built Academia houses Singapore General Hospital’s (SGH) pathology services and SingHealth’s research, education and training facilities in two towers. As the latest addition to SingHealth, Academia is a clear visual demonstration of the SingHealth group as an Academic Healthcare Cluster and a testament of SingHealth’s transformational journey to better patient care.

With a goal to pursue innovation and transform patient care delivery, Academia combines the best clinical and research capabilities to discover new and better treatment care for patients.

Designed to provide close proximity between research, diagnostic and education facilities within one state-of-the-art complex, Academia facilitates interconnectivity between clinician scientists, researchers, pathologists, educators and medical students, harnessing strengths to inspire better healthcare delivery.

Located close to clinical services on the SGH Campus and Duke-NUS Graduate Medical School, Academia, with three floors dedicated to education and training, will provide healthcare staff with access to simulated environments as well as education and skills laboratories to hone their clinical and surgical skills, nursing care and life support skills.

http://imsaj.com

Date: June 10-11, 2013
Venue: Bangkok, Thailand

http://www.siemens.com.sg/SPACe/schedule.asp

複数企業と連携、医療機器開発（３年から５年で確実に市場にでる開発）を行っています。５月には、アジアメディカルセンターと日本企業との共願特許がシンガポールから出願されました。

シンガポール規制当局、Healthcare Sciences Authority (HSA)からの認証獲得は、ルーチン化した作業となるまでに整備されました。 http://www.hsa.gov.sg/publish/hsaportal/en/home.html#page=tab1

ご　挨　拶

アジアメディカルセンター(AMC)は、この４月で公式発足から１年を迎えました。組織の本格的オペレーションがスタートしたのは昨年７月からであることを考えると、この短期間に非常に多くの方々とお知り合いになり、皆様方のアジア（一部アフリカ）進出をご支援させて頂くことができたことを大変嬉しく思っております。これらの活動が可能になった背景には、私共の活動にご賛同頂けたシンガポール、日本両国からの有形無形の多大なるご支援があったからにほかなりません。特に、シンガポール科学技術研究庁（Agency for Science, Technology and Research: A*STAR）のBiomedical Research Council (BMRC), Biomedical Science Institute (BMSI), A*STAR-Duke-NUS Graduate Medical School Neuroscience Research Partnership (NRP)の皆様方には多大なるご理解とご支援を頂きました。 更には、思いを同じにする日本企業の皆様、シンガポール、日本両国の医師の皆様、弁護士/弁理士の方々、AMCサポータの皆様と、AMCが最も大変であった時期に、常に変わらずご支援頂きましたこと深く感謝すると共に、深く御礼申し上げます。

AMCは、シンガポール現地法人格を有する組織であり、現時点では、NPO法人的な役割とプライベートセクターとしての役割の２つ兼ね備えております。プライベートセクターでは、企業と連携しビジネスに直結した活動を行っております。AMCでは、医療機器のアジア圏進出を専門医師の進出と共に相乗的に進めております。更に、今年６月には、３年から５年を目処に確実に市場にでる装置開発を行うための医療機器開発部門が発足し、来年にはAMCの研究室もオープンします。医療現場と共に、企業＆研究所と連携し医療機器開発を行っていきたいと考えております。事業が進めば進むほど、我々側も勉強することが多くなります。日々精進しながら成長し続けて行きたいと思っております。

今後も、皆様方とご一緒できることを楽しみにしております。引き続き宜しくお願い申し上げます。

２０１３年６月

代表　尾崎美和子

Singapore-UK Partnership aims to grow local medtech industry

Singapore, 30 May 2013:The Singapore Institute of Manufacturing Technology (SIMTech), a research institute of the Agency for Science, Technology and Research (A*STAR), and the University of Leeds of United Kingdom inked a Memorandum of Understanding today. The alliance aims to collaborate on the R&D of innovative medical devices in mutually identified areas such as lab on chips, medical implants and implantable devices which include innovative joint replacements and biological scaffolds for cardiovascular and musculoskeletal tissue regeneration to improve quality of life.

2. Leveraging on SIMTech’s core capabilities in manufacturing research to develop technologies relevant to the future needs of the medical devices manufacturing industry, this partnership stimulates Medtech innovations to help grow the medical device industry in Singapore. The Medtech industry is a growing market for the local precision engineering and components manufacturers. When equipped with the relevant capabilities, these industry clusters can diversify into the Medtech industry. As such, these sectors and medical professionals are expected to benefit from the co-operation and knowledge transfer.

3. The Singapore Medtech sector targets to achieve S$5 billion in manufacturing output by 2015, having grown from S$1.5 billion in 2000 to about S$4.3 billion in 2011. Over the same period, its manpower base more than doubled from about 4,000 to 9,000. The combination of an ageing population and growing affluence are fuelling the demand for high quality Medtech products. This presents tremendous opportunities for the local precision engineering companies and global Medtech companies to extend their presence in Singapore to address the healthcare needs in this region. Singapore is home to more than 30 Medtech companies which have set up commercial-scale plants to produce medical devices for the regional and global markets. In addition, all of the top 10 Medtech companies have their regional headquarters in Singapore, from which to drive business expansion in Asia (Source: Singapore Economic Development Board, 2012).

4. The collaboration with the University of Leeds, well known for its research in medical and biological engineering, will help to fill the gap between material and engineering research to translate research outcomes from the lab to manufacturing readiness. It will also boost the exchange of experience, knowledge and information; engagements of specialists / students for study and consultation and interactions between academia/researchers in both institutions. Funding opportunities, shared use of facilities, academic collaboration and joint organisation of scientific events will also be explored.

5. Dr Lim Ser Yong, Executive Director of SIMTech commented, “The collaboration is a synergistic platform to translate medical science breakthroughs and innovations to effective and affordable medical devices by leveraging on engineering and manufacturing research capabilities of both institutions. With SIMTech’s precision engineering and high value manufacturing capabilities coupled with a strong industry partnership track record, the institute is able to optimise its integrated technology capabilities in process, automation and manufacturing systems to grow the local Medtech industry.”

6. Professor John Fisher, Director of the Institute of Medical and Biological Engineering at the University of Leeds commented “We have seen a significant increase in demand for medical devices that is driven by the needs of the ageing population and an expectation for increased reliability and performance. The collaboration with SIMTech provides an excellent opportunity to support the development of medical devices that will more clinically and cost effectively match implant function and therapy to patient need. The Institute of Medical and Biological Engineering at Leeds University is well positioned with the world’s largest pre-clinical simulation facilities to determine the long-term performance of medical implants and an extensive experience of successful research translation and exploitation. This provides a highly complementary platform for long-term collaboration with colleagues at SIMTech.”

日時　　：　５月２０日(月)　シンポジウム１８：００～２０：３０/交流会２０：４０～２１：４０

場所　　：　大阪大学中之島センター http://www.onc.osaka-u.ac.jp/center/introduction/index.php

第１部　シンンポジウム

タイトル：医療国際化に向けた経済産業省の取り組み
演者　：経済産業省商務情報政策局ヘルスケア産業課　福島洋課長

タイトル：関西の底力を結集して世界へ　～関西イノベーション国際戦略総合特区をはじめとする医療・福祉分野での各地域活性化の取り組み～」
演者　：内閣官房地域活性化統合事務局　長谷川新次長

タイトル：産業としての医療
演者　：アジアメディアカルセンター　尾崎美和子代表

第２部　情報交換会

会場：９F　交流サロン「サロン・ド・ラミカル」

「第２回　医療と産業の国際交流シンポジウム　ｉｎ関西」

本年１月開催の「第１回 医療と産業の国際交流シンポジウムin関西」に引き続き、「第２回　医療と産業の国際交流シンポジウムin関西」が、５月２０日（月）大阪大学中之島センターで開催されました。平日の夕方開催にも関わらず120名を超える皆様のご参加を得て前回同様の満席開催となりました。

第1回シンポジウムは医療の海外事業展開を既に行っている３人の方々に事業の成功ポイントとそれを支えるビジネスモデルについてご講演頂き参加者との活発な質疑応答が行なわれました。第２回シンポジウムでは、医療の国際化に向けたビジネス展開を具体的に検討されている方、あるいはこの分野に興味はあったが今までつかみ所がはっきりわからないといったお悩みをお持ちの方々も含めて、より具体的な戦略立案に役立てて頂けるよう、国主導でどこまで進んでいるのか、国主導と民間主導の線引きは、協力体制に関してどのように考えれば良いのか、関西での医療特区の進展状況はどの様になっていて、今後この分野に参入するにはどこがチャンスなのか、実際に海外に進出する際には海外ネットワークをどのように活用できるのか等々の疑問点に対し３人の講師の方々から具体的な事例と成功へのポイントについてご講演頂きました。

　-経済産業省 商務情報政策局 ヘルスケア産業課長 　　福島　洋様
　-内閣官房 地域活性化統合事務局 次長 　　長谷川　新様
　-アジアメディカルセンター（シンガポール）代表　　　尾崎　美和子様

非常にわかりやすく、示唆に富む、めったに聞くことが出来ない大変貴重なご講演となり、全員が熱心に耳を傾け、吉川敏一座長(当機構理事長)リードのもとで今回も又、活発な質疑応答、意見交換が行なわれ大変有意義なシンポジウムとなりました。

以下に３人の講師の皆様のご講演内容を紹介させていただきます。

福島洋様からは、「医療国際化に向けた経済産業省の取り組み」と題して、先ず国の取り組みとして将来あるべき姿を「戦略目標」として４項目を設定、国民の「健康長寿」の延伸がその一つとして大きくクローズアップされていることをご教示頂きました。健康寿命伸長産業を育成するにあたり、予防・健康維持、治療、介護・自立支援の３分野に分けて、保険外産業の育成、最先端治療の海外輸出など今後のロードマップを具体的に計画されていることを強調されました。
実際、海外での我が国の高度かつきめ細やかな医療に対するニーズは非常に高く、それに応えるためにも医療サービス事業者と医療機器メーカーが一体となって海外展開する事が必要であると経済産業省では考えていること、その具体的な展開事例として、ロシア、カンボジアでの施策事例と今後の展望についてご講演頂きました。

長谷川新様からは「関西の底力を結集して世界へ～イノベーション国際戦略総合特区など医療・福祉分野での地域活性化の胎動～」と題して、国際競争に打ち勝つためには先端医療を積極的に育てて行くと同時に、総合特区を成長させて行く必要があると国が考えていることについてご講演いただきました。 具体的には成長戦略の一つである総合特区が、規制の特例や経済的支援を伴う「民と公総がかり」、「地域と国総がかり」の国際競争・地域活性化戦略であり、関西では、医薬品、医療機器、先端医療技術、先制医療などのイノベーション・プラットフォームを築く国際戦略総合特区が京阪神6府県市共同で進行中であること、そしてその最大目標は世界市場でのシェア倍増であるという力強い内容です。その実現にむけて規制・制度を今こそイノベーションの障害から促進力に変える必要があり、多様な企業や公的機関が密接に連携し、地域資源を最大限に有効活用することが最も重要であり、超高齢化の課題を世界に先駆けて解決し、世界の範となるための戦略が重要であるとご講演頂きました。

尾崎美和子様からは「産業としての医療」と題して、既にシンガポールでは、医療は産業として成り立っていること、その成り立ちから現在の発展状況やこれまでの日本での「医療産業」の捉え方との違いについてご自身のシンガポールでの活動経験をもとに具体的にご提示いただきました。 アジア諸国では、既に『医療』を産業と捉え様々なビジネスが展開されている、その理由は発展途上であった国を発展させていく原動力として、医療産業が最もリスクが低く、最良の選択であったことなど、日本の医療産業の捉え方との違いについても事例紹介をしていただきました。その先端を進むのがシンガポールであり、医療を産業として発展させることで国の負担をできるだけ小さくしつつ、医療を様々な形で様々な階層に提供出来ることが可能となっている、更に医療産業が医療技術(基盤技術をも含む)の進歩を急速に促す結果となっていること、そして何故日本では医療産業が成り立ち難いのか、何故日本はその他アジア周辺国にさえ追い抜かれているのか、国民皆保険制度の功罪とともに、医療サービスの差別化をすることが医療を産業として発展していくためには必要不可欠な事であることを、アジアメディカルセンターでの活動実績をもとに具体的にご提示いただき、参加者全員にとって示唆に富む盛りだくさんのご講演でした。

第２部の情報交換会も、シンポジウムに参加された殆ど全員の多くの方がご参加され、活発に相互交流をされました。閉会時には、次回への期待が益々高まる名残惜しさが一杯の情報交換会となりました。（これは第１回シンポジウムの時と全く同じ熱気あふれる状況でした）

第３回シンポジウムは本年９月初旬頃の予定です。平日だけでなく土曜日にも開催してほしいというご要望にお応えして、次回は土曜日の開催予定です。開催概要が決まりましたら速やかにご案内させていただきます。当シンポジウムは毎回、産・官・学・医各界の優れた講師の方々にご登壇頂き、次代を先導する視座や知見、先進事例などをご講演いただきますので、次回もどうぞご期待ください。

(文責　理事　木村　修）

株）シキノハイテク
http://www.shikino.co.jp

AsiaCORD2013学術集会のご案内；
会期：2013年4月19(金)-20日(土)
会場：神戸ポートピアホテル
　　　〒650-0046 神戸市中央区港島中町6丁目10-1
　　　http://www.portopia.co.jp/

AsiaCORD2013会長浅野茂隆
　準備事務局　責任者　長村登紀子
　同　　　　　事務担当　中野
　東京大学医科学研究所附属病院セルプロセッシング・輸血部

asiacord2013@crmsa.or.jp　　盛 http://www.asiacord.umin.jp

AsiaCORD本部：(特)アジア医学融合科学研究戦略ネットワーク
　神戸バイオテクノロジー(BT) センター207号
　同・千葉事務所：学会運営事務局合同会社　担当：中野

office.chiba@crmsa.or.jp　　 http://crmsa.or.jp

＜AsiaCORD2013_Program 130406.pdf＞
＜AsiaCORD2013 _General Info.pdf＞

主な参加者は下記です。

A*STAR Chairman Lim Chuan Poh, Biomedical Research Council Executive Director Benjamin Seet, Biomedical Research Council Director of Industry Development Jonathan Kua, Genome Institute of Singapore Executive Director Ng Huck Hui, EDBI Executive Vice President, Corporate Finance & Planning, Eugene Khoo, Economic Development Board Head of Medical Technology Lim Tse Yong, Fluidigm Co- founder, President and Chief Executive Officer Gajus Worthington, Fluidigm Executive Vice President, Research & Development Robert Jones, and Fluidigm Executive Vice President, Worldwide Manufacturing, and Managing Director of Fluidigm Singapore Grace Yow.

Press release - Official Opening GIS-Fluidigm SCOC 20130412 FINAL.pdf

Genomic medicine is expected to advance the way to predict and diagnose disease and individualize patient treatment. In order to improve the development of personalized medicine, the challenge relies on the integration of genomics, proteomics, and transcriptomics to achieve an integrative view of the biology of disease

Date: Friday, 12 April 2013
Time: 9:00 AM - 5:30 PM
Location: Grand Park City Hall, 10 Coleman St., Singapore 179809

Please join us in this all-day seminar where you will listen to international experts talk about how they are using different "omic" technologies to improve diagnosis and treatment of disease. Featured speakers include:

This seminar is free of charge but seating is limited, so please register below.
http://www.regonline.com/Register/Checkin.aspx?EventId=1207501

＜Omics in the Clinic Conference Series Agenda_Singapore.pdf＞

MTA2013 serves highly-complex industry verticals such as Aerospace, Electronics, Energy, Medical and Oil & Gas.
With the growing demand for fully integrated capabilities in the most demanding manufacturing environments and sophisticated processes to provide fast, reliable and highest level of precision, MTA 2013 gathers innovative technologies and cost effective solutions while optimising resources to deliver consistent performance.
Discover new technology trends and markets.
Gain new perspectives and stay relevant in this fast-moving marketplace./p>

Web Site: http://www.mta-asia.com

日時：4月9日（火）～12日（金） 10:30～18:00

会場：シンガポール・エキスポ

料金：展示会見学は無料（事前登録要）。会議参加は有料。

注意：ビジネス関係者のみ入場可。

On behalf of the organizing committee of World Autism Awareness Week (WAAW), I would like to cordially invite you to our Autism Seminar Series.

This seminar is organized by students of Duke-NUS’ Benjamin Sheares College, in conjunction with Autism Association (Singapore), Autism Resource Centre (Singapore), Rainbow Centre and St. Andrew’s Autism Centre, as part of this year’s WAAW.

This year, we are honored to have with us Mr Richard Mills, Director of Research, The National Autistic Society, UK. Mr Mills will give a keynote address on the National Institute for Health and Clinical Excellence (NICE) Guidance on Adults with Autism. This keynote address will then be followed by a series of two talks organized especially for medical professionals.

Details of the seminar are as follows:

Time: Saturday, 6 April 2013, 8am-1pm (Breakfast will be provided)

Venue: Pathlight School Campus 1, 5 Ang Mo Kio Ave 10 S(569739)

特別講演　15：00～16：30

Seminar:
1) 'Autism - A Spectrum of Opportunities' by Dr Daniel Fung, Chairman, Medical Board, Institute of Mental Health
2) 'Caring for Children with Autism from a Professional Perspective' by Dr Chin Chee Hon, Consultant, Department of Child and Adolescent Psychiatry, Institute of Mental Health

Participants will also have an opportunity to raise any questions at our joint panel discussion which will be held after the talks to wrap up the seminar meaningfully.

＜Autism Seminar .pdf＞

今回の都市開発は都市の再緑化が主テーマと思われますが、今後の医療ビジネスでは、都市開発との連携（都市計画時から医療やヘルスケアに必要な情報通信や施設を組み込んでいく方法）が加速されると思われます。本件、現時点で医療とは関係ありませんが、医療に結びつく可能性の高い情報として提供しています。

＜Press_Release_for_ASTAR-Fujitsu_MoU_Singapore.pdf＞

Location: Exploration Theatrette, Matrix Building Level 4, Biopolis, Singapore

Date & Time: 13th March 2013, 10 am to 5 pm

Organisers: IMB-IMCB Joint Electron Microscopy Suite

＜Seminar 20130313a.pdf＞

株）三井物産ニュースリリース
http://www.mitsui.com/jp/ja/release/2013/1199888_4689.html

関連記事
http://www.nikkei.com/news/print-article/?R_FLG=0&bf=0&ng=DGXNASDD040HT_U3A300C1TJ1000
http://release.nikkei.co.jp/detail.cfm?relID=331995&lindID=2
http://kaigaibusiness.com/トピックス/7681.html
http://newsbiz.yahoo.co.jp/detail?a=20130304-00000505-biz_san-nb
http://www.newsclip.be/news/2013305_037372.html
http://blog.goo.ne.jp/thinklive/e/9e83d21389ae6bca4d95276b65249dd7
http://www.nangoku.com.my/20130305-1304/
その他報道多数

日時　　：　 平成25年 2月21日（木）　14：00 より

場所　　：　特別講演等の会場　　　 東京シティ・エア・ターミナル
　 　　　　　総会後懇親会の会場　　 東京シティ・エア・ターミナル２F「龍鳳」

特別講演　15：00～16：30

1. 15:00～15:20
「インドネシア医療事情」
演者　：渋谷　豊彦 氏　（デンカ生研）

2. 15:30～16:30
「シンガポールを中心としたアジア医療機器開発と医療ビジネスの現状」
演者　：尾崎　美和子氏（アジアメディカルセンター　代表）

懇親会　　16：45 ～ 18：30